Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas

96Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

Carcinoma of the thyroid gland is an uncommon cancer, but one of the most frequent malignancies of the endocrine system. Most thyroid cancers are derived from the follicular cells. Follicular carcinoma is considered more malignant than papillary thyroid carcinoma (PTC), and anaplastic thyroid cancer (ATC) is one of the most lethal human cancers. Even though several genetic lesions have been already described in human thyroid cancer, particularly in the papillary histotype, the mechanisms underlying the development of these neoplasias are still far from being completely elucidated. Some years ago, several studies were undertaken to analyze the expression of microRNAs (miRNAs or miRs) in thyroid carcinoma to evaluate a possible role of their deregulation in the process of carcinogenesis. These studies showed an aberrant microRNA expression profile that distinguishes unequivocally among PTC, ATC, and normal thyroid tissue. Here, other than summarizing the current findings on microRNA expression in human thyroid carcinomas, we discuss the mechanisms by which microRNA deregulation may play a role in thyroid carcinogenesis, and the possible use of microRNA knowledge in the diagnosis and therapy of thyroid neoplasms. © 2010 Society for Endocrinology Printed in Great Britain.

Cite

CITATION STYLE

APA

Pallante, P., Visone, R., Croce, C. M., & Fusco, A. (2010, March). Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas. Endocrine-Related Cancer. https://doi.org/10.1677/ERC-09-0217

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free